⌘K

16:16:26·1336d

INSIDERFilingvia Quantisnow

SEC Form 3 filed by new insider Mansbach Samuel Ross

ByQuantisnow·Wall Street's wire, on your screen.

ESTA· Establishment Labs Holdings Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

ESTA
Establishment Labs Holdings Inc.
Health Care

Recent analyst ratings

Aug 20UpdateCanaccord Genuity$60.00
May 16UpdateBTIG Research$62.00
May 14UpdateNeedham$48.00
Apr 14UpdateNeedham-
May 22UpdateCitigroup$60.00
Aug 31UpdateJP Morgan$75.00

Related

INSIDER1d
Director Chacon Quiros Juan Jose sold $4,919,478 worth of shares (75,000 units at $65.59) as part of a pre-agreed trading plan (SEC Form 4)
SEC4d
SEC Form DEFA14A filed by Establishment Labs Holdings Inc.
PR5d
Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6
INSIDER12d
SEC Form 4 filed by Chacon Quiros Juan Jose
SEC18d
SEC Form DEFA14A filed by Establishment Labs Holdings Inc.
SEC18d
SEC Form DEF 14A filed by Establishment Labs Holdings Inc.
INSIDER20d
Amendment: SEC Form 4 filed by Caldini Filippo
PR21d
Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market